High Serum Levels of iNOS and MIP-1α are Associated with Post-Stroke Depression
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Purpose: Post-stroke depression (PSD) is one of the emotional disorders after the onset of stroke. Many studies have indicated that inflammatory processes can promote the occurrence and development of PSD. The purpose of our study was to explore the potential relationship between PSD and two inflammatory biomarkers: inducible nitric oxide synthase (iNOS) and macrophage inflammatory protein 1α (MIP-1α). Methods: In total, 80 patients diagnosed with depression after the first-ever acute ischemic stroke were enrolled in PSD group consecutively. During the same period, 40 non-depressed patients following the first-ever acute ischemic stroke and 40 healthy control subjects were recruited as non-PSD group and normal group, respectively. All participants have performed serum iNOS and MIP-1α level examination with enzyme-linked immunosorbent assay (ELISA). The severity of depressive symptoms was evaluated by the 24-item Hamilton Depression Scale (HAMD-24). Results: Serum iNOS and MIP-1α levels were significantly higher in PSD group than those in non-PSD and normal groups ( P < 0.001). Serum iNOS and MIP-1α levels of PSD patients with varying degrees of depression were significantly different, serum iNOS and MIP-1α levels became higher as the depressive symptoms became more severe ( P < 0.05). There was a positive correlation between the elevated levels of iNOS, MIP-1α and HAMD scores ( r = 0.262, 0.209, P < 0.05). Logistic regression analysis showed that both serum iNOS and MIP-1α levels were independently associated with PSD (OR = 2.790, 95% CI: 0.712– 10.933, P < 0.05 and OR = 1.922, 95% CI: 0.648– 9.815, P < 0.05, respectively) after adjustment for possible relevant confounders. Conclusion: High serum levels of iNOS and MIP-1α were found to be associated with the development of PSD and closely related to its severity. Keywords: post-stroke depression, inducible nitric oxide synthase, macrophage inflammatory protein 1α, HAMD scores
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A more recent study demonstrated that elevated serum levels of MIP-1α and iNOS are associated with post-stroke depression [187].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [187]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Campbell, B. C. V., De Silva, D. A., Macleod, M. R., Coutts, S. B., Schwamm, L. H., Davis, S. M., & Donnan, G. A. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0118-8 · Cited by 1,750 · cited 1×
“and treatment of stroke, it remains an urgent problem to be solved due to its high recurrence rate and serious complications.(2,3) Stroke survivors tend to be left with different degrees of physical and psychiatric disabilities.”
Severity classification on the Hamilton depression rating scale
Zimmerman, M., Martinez, J. H., Young, D., Chelminski, I., & Dalrymple, K. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.028 · Cited by 1,199 · cited 1×
“The PSD group was divided into mild PSD group (8–16), moderate PSD group (17–23) and severe PSD group (≥ 24) according to HAMD scores.(22) During the same period, 40 non-depressed patients after the first-ever acute ischemic stroke and 40 healthy control subjects were recruited as non-PSD group and normal group, respe…”
MethodCampbell, B. C. V., & Khatri, P. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31179-x · Cited by 1,116
National Institutes of Health Stroke Scale (NIHSS)
Kwah, L. K., & Diong, J. (2014) · Journal of Physiotherapy · doi:10.1016/j.jphys.2013.12.012 · Cited by 811
The physiology and pathophysiology of nitric oxide in the brain
Guix, F. X., Uribesalgo, I., Coma, M., & Muñoz, F. J. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.001 · Cited by 713 · cited 1×
“It has been found that both iNOS and MIP-1α play a vital role in the occurrence of depressive disorders and the levels of them were increased.(25,26) However, there is no direct evidence to confirm the association between iNOS and MIP-1α levels and depression after acute stroke.”
BackgroundNitric Oxide in the Nervous System
Zhang, J., & Snyder, S. H. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.001241 · Cited by 513 · cited 2×
“Of the three isoforms of NOSs, inducible nitric oxide synthase (iNOS) is mainly involved in the production of NO under inflammatory conditions and particularly relevant to neuropsychiatric disorders.(9) Some studies have suggested that iNOS can induce the occurrence and development of depression through neuroinflammat…”
BackgroundPost stroke depression: epidemiology, pathophysiology, and biological treatment
Whyte, E. M., & Mulsant, B. H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01424-5 · Cited by 488 · cited 1×
“The main clinical symptoms of PSD include somnipathy, depression, anxiety and even suicide.(6) The etiology and Correspondence: Fuping Shi Department of Neurology, Affiliated Hospital of Hebei University, No.”
BackgroundWhat is a mental/psychiatric disorder? From DSM-IV to DSM-V
Stein, D. J., Phillips, K. A., Bolton, D., Fulford, K. W. M., Sadler, J. Z., & Kendler, K. S. (2010) · Psychological Medicine · doi:10.1017/s0033291709992261 · Cited by 477 · cited 1×
“(5th edition) (DSM-V).(21) The 80 patients diagnosed with depression after the first-ever acute ischemic stroke were enrolled in PSD group.”
Background
Cited by
Selected biomarkers of depression: what are the effects of cytokines and inflammation
Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010578 · Cited by 299
Tang, X., Liao, R., Li-jun, Z., Yang, L.-L., Ma, Z.-L., Yi, C., Liu, J., Liu, J.-C., Kuang, Y.-J., Cai, H., et al. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-5443 · Cited by 34
RetractedElevated monocyte-to-HDL cholesterol ratio predicts post-stroke depression
Li, Y., Zhang, M., Xue, M., Liu, D., & Sun, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.902022 · Cited by 27
Self-citationLifetime pathogen burden, inflammatory markers, and depression in community-dwelling older adults
Lu, Y., Liu, B.-P., Tan, C. T., Pan, F., Larbi, A., & Ng, T. P. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.02.020 · Cited by 20
NLRP3 Inflammasome: A New Target for the Treatment of CVD and Depression Comorbidity
Chen, C., Zhang, S., Sheng, M., & Shao, W. (2025) · Mediators of Inflammation · doi:10.1155/mi/4330574 · Cited by 18
“Studies have shown that in fl ammatory cytokine levels are elevated in both PSD patients and animal models, accompanied by the activation of the TLR4/p38/NF-κ B/NLRP3 pathway [144, 145].”
Characteristics of Gut Microbiota and Plasma Metabolites in Patients with Post-Stroke Depression
Yan, C., Si, T., Zheng, W., Huang, L., Wen, L., Shen, H., & Qu, M. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s494035 · Cited by 14
de Lima, B. R. F., Patriota, L. L. D. S., Marinho, A. D. O., da Costa, J. A., Napoleão, T. H., da Rosa, M. M., & Paiva, P. M. G. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137092 · Cited by 12
Li, Y., Zhang, M., Dong, C., Xue, M., Li, J., & Wu, G. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s351136 · Cited by 7
Self-citationZhang, G., Zhou, X., Feng, Q., Ke, W., Pan, J., Zhang, H., Luan, Y., & Lei, B. (2024) · Neuroreport · doi:10.1097/wnr.0000000000002029 · Cited by 3
“This study also detected the expression of iNOS, which has been identified as a biomarker in clinical studies monitoring patients with depression [26].”
BackgroundNomogram combined neuron-specific enolase and NIHSS for prediction of post stroke depression
Yan, C., Zheng, W., Si, T., Huang, L., Wen, L., Shen, H., & Qu, M. (2025) · International Journal of Neuroscience · doi:10.1080/00207454.2025.2488758 · Cited by 3
“Patients with hDRs scores ≥ 8 were diagnosed with PsD, and these patients also met the diagnostic criteria of the Diagnostic and statistical Manual of Mental Disorders, 5th edition (DsM-V) [19].”
Janković, M., Spasojević, N., Ferizović, H., Stefanović, B., Virijević, K., & Dronjak, S. (2025) · Physiology & Behavior · doi:10.1016/j.physbeh.2025.114893 · Cited by 2
Zeng, M., Zhou, H., Zeng, L., zhang, M., Yang, J., Geng, W., & Wan, H. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111747 · Cited by 1
Self-citationResearch Progress on the Mechanism, Risk Factors and Evaluation of Post-Stroke Depression
邓, 丽. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.1112857
Jose, D. A., Tripathi, A., Madeshiya, A. K., Todd, T., Quevedo, J., & Pillai, A. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00248-7
Metadata
- Authors
- Wang, X., Fang, C., Liu, X., Wei, W., Zhang, M., Chen, S., & Shi, F.
- Affiliations
- Affiliated Hospital of Hebei University (CN)
- Corresponding author
- Shi, Fuping
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2021-07
- Volume
- Volume 17
- Pages
- 2481-2487
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- PMC
- PMC8326775
- OpenAlex
- W3186873814
- Cited by
- 14
- References
- 43
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 1 · 2023: 1 · 2022: 5 · 2021: 1
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- Hebei University
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- post-stroke depression, inducible nitric oxide synthase, macrophage inflammatory protein-1alpha, serum inflammatory markers, ischemic stroke, depression severity, neuroinflammation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.